Filing Details
- Accession Number:
- 0001209191-21-051915
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-17 17:01:36
- Reporting Period:
- 2021-08-13
- Accepted Time:
- 2021-08-17 17:01:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1584751 | Talis Biomedical Corp | TLIS | Laboratory Analytical Instruments (3826) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1845434 | Ramesh Ramakrishnan | C/O Talis Biomedical Corporation 230 Constitution Drive Menlo Park CA 94025 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-13 | 43,614 | $1.50 | 57,380 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-08-13 | 8,741 | $1.50 | 66,121 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-13 | 27,502 | $7.66 | 38,619 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-08-13 | 43,614 | $0.00 | 43,614 | $1.50 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-08-13 | 8,741 | $0.00 | 8,471 | $1.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-08-14 | No | 4 | M | Direct | |
| 0 | 2021-08-14 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.
- 1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.
- 25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.
Billionaire Hedge Funds
